Pepperl+Fuchs GB Limited
Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Company Details
Latest Content from PMHub
Nutraceuticals: Rich in Potential
White Papers and Resources | November 23, 2016 | Inizio
Published in eyeforpharma October 2016 by Marc Yates
Case Study: Qualitative research with payers in low and middle income countries
White Papers and Resources | November 23, 2016 | Inizio
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in...
Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers
White Papers and Resources | November 23, 2016 | Inizio
In association with PMGroup
Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community
White Papers and Resources | November 23, 2016 | Inizio
Our client wanted to understand why uptake of HPV vaccination in the Asia-Pacific region was limited. In order to help increase uptake, they wanted to publish the market research findings...
Towards a culture of evaluation and evidence-based decision making in global health
White Papers and Resources | November 23, 2016 | Inizio
Reflections on THET Conference 2016: Evidence, Effectiveness & Impact
Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016
White Papers and Resources | November 23, 2016 | Inizio
Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including...
The Internet of Things
White Papers and Resources | November 23, 2016 | Inizio
Evolution from man to machine
Therapy Watch expands its oncology portfolio
White Papers and Resources | November 23, 2016 | Inizio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio...
Time for a new language for asthma?
White Papers and Resources | November 23, 2016 | Inizio
Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines....
Evaluating the impact of your medical congress presence…more cost effectively
White Papers and Resources | November 23, 2016 | Inizio
Organising a company’s presence, not just logistically, but in terms of delivering key information, data and messages, is a massive part of some people’s workload at this time of year....